Akèy › Mesotelyom › Texas › Houston
Etid klinik pou Mesotelyom nan Houston, TX
15 etid pou Mesotelyom ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
SW-682 in Advanced Solid Tumors
Ap rekriteFaz 1
- U.T. MD Anderson Cancer Center, Houston
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Ap rekriteFaz 1/2Volontè an sante akeyi
- Baylor St Lukes, Houston
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- The University of Texas MD Anderson Cancer Center, Houston
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Ap rekriteFaz 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Ap rekriteFaz 1
- MDACC, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
A Study of VET3-TGI in Patients With Solid Tumors
Ap rekriteFaz 1
- University of Texas MD Anderson Cancer Center, Houston
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Ap rekriteFaz 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
Etid Mesotelyom nan lòt vil
- New York City, NY10 etid
- Washington, DC9 etid
- Chicago, IL9 etid
- Nashville, TN8 etid
- Boston, MA8 etid
- Arlington, VA6 etid
- Philadelphia, PA6 etid
- Pittsburgh, PA6 etid
- Seattle, WA6 etid
- Los Angeles, CA6 etid
- Rochester, MN5 etid
- Columbus, OH5 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.